## Clinical Diagnosis: Uterine Leiomyomas (Fibroids) ### Key Findings in This Case **Key Point:** The combination of heavy menstrual bleeding (menorrhagia), regular cycle (every 21 days), enlarged irregularly nodular uterus on palpation, and multiple hypoechoic myometrial lesions on ultrasound is pathognomonic for uterine leiomyomas. ### Pathophysiology of Menorrhagia in Fibroids 1. Increased endometrial surface area (submucosal fibroids distort the cavity) 2. Abnormal angiogenesis and increased vascular permeability 3. Impaired uterine contractility → prolonged bleeding 4. Elevated local prostaglandins and growth factors ### Distinguishing Features: Leiomyomas vs. Adenomyosis | Feature | Leiomyomas | Adenomyosis | |---------|-----------|-------------| | **Uterine size** | Irregular, nodular, asymmetric | Uniformly enlarged, boggy | | **Bleeding pattern** | Heavy, regular cycles (if submucosal) | Heavy + dysmenorrhea common | | **Ultrasound** | Discrete hypoechoic masses with whorled pattern | Heterogeneous myometrium, no discrete mass | | **MRI findings** | Well-defined fibroids with junctional zone intact | Disrupted junctional zone, diffuse involvement | | **Age of presentation** | 30–50 years (reproductive age) | 40–50 years (perimenopausal) | **High-Yield:** Leiomyomas are the most common pelvic tumor in women; menorrhagia is the most common presenting symptom. ### Why This Patient Has Leiomyomas, Not Adenomyosis - **Adenomyosis** presents with dysmenorrhea (which this patient lacks) and a uniformly enlarged, boggy uterus; ultrasound shows heterogeneous myometrium without discrete masses. - The **irregular nodular** uterus and **discrete hypoechoic lesions** point to fibroids. - Regular 21-day cycles (not prolonged or irregular) favor fibroids over adenomyosis. ### Clinical Management Approach **Tip:** In reproductive-age women with menorrhagia and fibroids, first-line medical options include: - Combined oral contraceptives (COCs) - Levonorgestrel intrauterine device (LNG-IUD) — most effective for menorrhagia - NSAIDs (mefenamic acid 500 mg TDS during menses) - Tranexamic acid (1.3 g TDS for 4 days during menses) Surgical options (myomectomy, hysterectomy) are considered if medical therapy fails or fertility is desired. **Clinical Pearl:** Fibroids regress after menopause due to loss of estrogen and progesterone stimulation; therefore, expectant management is reasonable in perimenopausal women with tolerable symptoms. [cite:Ferenczy & Bergeron, 2011; ACOG Practice Bulletin 228]
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.